In secondary, intention-to-treat analyses, participants were followed from the index date to first SIS event, death, or end of follow-up, and were analysed according to the treatment assigned at baseline, irrespective of actual exposure during follow-up
The injection pens for Ozempic and Wegovy do not deliver the prescribed dose with a single touch of a button
Results vary and carry potential risks
Semaglutide is not a one-size-fits-all solution
This may include incorporating more fluids into your day, changing some of the foods you eat, or waiting until after a planned vacation to start with injections
Should be preferred: Applied when at least one Phase III randomized controlled trial with prespecified, phenotype-specific primary endpoints demonstrated clinically meaningful benefit, with regulatory approval and no major safety concerns